Friday, April 23rd, 2PM EDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Practically speaking about lupus anticoagulants and women's health: Part 1 of a series to learn about a paradoxical problem

Sponsored by: Diagnostica Stago, Inc.
C.E. Credits: P.A.C.E. CE Florida CE
  • Dir. Scientific Affairs Market Access Group

      Daniel A Kaczor graduated in June of 1980 from Utica College of Syracuse University where he earned his Bachelor’s in Science in Medical Technology. He became board certified by the College of American Pathologists in August of 1980. Dan’s entire professional career has been dedicated to the field of Hemostasis and Thrombosis. His tenure with Stago encompasses the last 28 years. He is currently the Director, Scientific Affairs, Market Access Group for Stago. Prior to this, he was the Director, Advanced Support Group, a department that encompassed hotline, customer/employee technical training, second level support and clinical and scientific research. Upon joining Stago, he held the position of Director, Technical Service Department. Before joining Stago, Dan spent 14 years in clinical laboratory medicine either as a Coagulation Specialist or as Supervisor of the Coagulation Department. He is the developer of the Platelet Neutralization Procedure and the 4 to 1 APTT Mixing Study, two tests that are performed globally for the detection of Lupus Anticoagulants. His 40-year career has been highlighted by numerous National as well as International publications and speaking engagements related to Hemostasis and Thrombosis.

    • Technical Support Specialist - Diagnostica Stago Inc.

        Katy Whelchel has worked at Diagnostica Stago since 2001. Her roles at Stago have included Technical Support Specialist, Advanced Support Group, Clinical Research Associate and Technical Sales Representative. Previously she was Laboratory Supervisor at St. Mary’s Hospital in Rogers, Arkansas. She was Hematology Clinical Instructor for University of Arkansas Medical Sciences’ Medical Technology Program, as well as a member of the Mercy System Hematology/Coagulation Standardization Committee. Katy is co-author of five coagulation publications, a member of 3 CLSI Committees, and gives many presentations on Coagulation topics each year throughout the United States. In her spare time, she and her husband ride their motorcycle throughout the continental US. Katy is also an avid reader, and English Handbell aficionado.


      Practically speaking about lupus anticoagulants and women's health:
      Part 1 of a series to learn about a paradoxical problem

      Lupus anticoagulants are consistently present in patients at risk of thrombosis as a result of underlying antiphospholipid syndrome (aPS), a dangerous disorder treated by prophylactic anticoagulation using well-established methods. Our webinar, part of an ongoing series will give an overview of antiphospholipid syndrome, available clotting-based methods, validation procedures, and link in relevance to women’s health. The information provided will bring together different pieces of the overall but paradoxical picture of aPS, allowing for a full picture of the relevance in the overall care pathway.


      Learning Objectives

      1. Provide overview of lupus anticoagulants assays with emphasis not only on overall methods but commonly performed validation procedures
      2. Present linkage of lupus anticoagulants to patient care pathway for confirmed aPS patients
      3. Demonstrate relevance of aPS to real life patient situations

      Show Resources
      Show Resources
      Event Countdown
      • 0 Days
      • 0 Hours
      • 0 Minutes
      • 0 Seconds
      • See more